Acute Severe Visual Decrease After Photodynamic Therapy with Verteporfin: Spectral-Domain OCT Features
Authors:
- Pearse A. KeanePKPearse A. Keane
- Elda AghaianEAElda Aghaian
- Yanling OuyangYOYanling Ouyang
- Lawrence P. ChongLCLawrence P. Chong
- Srinivas R. SaddaSSSrinivas R. Sadda
- 1 November 2010
- journal article
- case report
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 41 (S1) , S85-8
Abstract
In this report, spectral-domain optical coherence tomography (OCT) was used to characterize the acute morphologic alterations that occur when photodynamic therapy with verteporfin results in an acute severe visual decrease. The clinical and imaging records of a patient with neovascular age-related macular degeneration who suffered this complication were reviewed. Using spectral-domain OCT, two relatively distinct subretinal fluid compartments were visualized: a sparsely hyperreflective pocket of subretinal fluid overlying the fibrovascular pigment epithelial detachment, consistent with fibrinous exudation, and a more homogenously hyporeflective compartment at the periphery of the choroidal neovascular lesion, consistent with serous exudation. The higher axial resolution, and greater sensitivity, of spectral-domain OCT allows improved visualization of the subretinal space. As experience with spectral-domain OCT grows, new parameters will emerge—such as those related to subretinal fluid—that will facilitate improvements in both the qualitative and quantitative evaluation of macular disease.Keywords
This publication has 13 references indexed in Scilit:
- Combination of verteporfin photodynamic therapy and ranibizumab: effects on retinal anatomy, choroidal perfusion and visual function in the protect studyBritish Journal of Ophthalmology, 2008
- Same-day administration of verteporfin and ranibizumab 0.5 mg in patients with choroidal neovascularisation due to age-related macular degenerationBritish Journal of Ophthalmology, 2008
- Management of neovascular age-related macular degenerationProgress in Retinal and Eye Research, 2007
- Time Course and Morphology of Vascular Effects Associated with Photodynamic TherapyOphthalmology, 2005
- Complications After Photodynamic TherapyArchives of Ophthalmology (1950), 2005
- Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials—TAP and VIP report no. 3American Journal of Ophthalmology, 2004
- IMMEDIATE INDOCYANINE GREEN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY EVALUATION AFTER PHOTODYNAMIC THERAPY FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATIONRetina, 2003
- Optical coherence tomography findings following photodynamic therapy of choroidal neovascularizationAmerican Journal of Ophthalmology, 2002
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinArchives of Ophthalmology (1950), 1999